Global Oncolytic Virus Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 95

Published Date: 05 Jun 2021

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Oncolytic Virus Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Oncolytic Virus Therapy size is estimated to be USD 12 million in 2026 from USD 5 million in 2020, with a change XX% between 2020 and 2021. The global Oncolytic Virus Therapy market size is expected to grow at a CAGR of 23.8% for the next five years.

Market segmentation
Oncolytic Virus Therapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    HSV-based Oncolytic Viruses
    Adenoviruses-based Oncolytic Viruses
    Vaccinia Virus-based Oncolytic Viruses
    Vesicular Stomatitis Virus-based Oncolytic Viruses
    Newcastle Disease Virus-based Oncolytic Viruses

Market segment by Application, can be divided into
    Melanoma
    Prostate Cancer
    Breast Cancer
    Ovarian Cancer
    Others

Market segment by players, this report covers
    Amgen
    Oncolytics Biotech
    Viralytics
    Transgene SA
    Oncolys BioPharma
    Targovax
    PsiOxus Therapeutics
    SillaJen Biotherapeutics
    Sorrento Therapeutics
    Lokon Pharma
    Genelux Corporation
    Vyriad
    TILT Biotherapeutics
    Cold Genesys

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Oncolytic Virus Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Oncolytic Virus Therapy, with revenue, gross margin and global market share of Oncolytic Virus Therapy from 2019 to 2021.
Chapter 3, the Oncolytic Virus Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Oncolytic Virus Therapy market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Oncolytic Virus Therapy research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Oncolytic Virus Therapy
    1.2 Classification of Oncolytic Virus Therapy by Type
        1.2.1 Overview: Global Oncolytic Virus Therapy Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Oncolytic Virus Therapy Revenue Market Share by Type in 2020
        1.2.3 HSV-based Oncolytic Viruses
        1.2.4 Adenoviruses-based Oncolytic Viruses
        1.2.5 Vaccinia Virus-based Oncolytic Viruses
        1.2.6 Vesicular Stomatitis Virus-based Oncolytic Viruses
        1.2.7 Newcastle Disease Virus-based Oncolytic Viruses
    1.3 Global Oncolytic Virus Therapy Market by Application
        1.3.1 Overview: Global Oncolytic Virus Therapy Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Melanoma
        1.3.3 Prostate Cancer
        1.3.4 Breast Cancer
        1.3.5 Ovarian Cancer
        1.3.6 Others
    1.4 Global Oncolytic Virus Therapy Market Size & Forecast
    1.5 Global Oncolytic Virus Therapy Market Size and Forecast by Region
        1.5.1 Global Oncolytic Virus Therapy Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Oncolytic Virus Therapy Market Size by Region, (2016-2021)
        1.5.3 North America Oncolytic Virus Therapy Market Size and Prospect (2016-2026)
        1.5.4 Europe Oncolytic Virus Therapy Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Oncolytic Virus Therapy Market Size and Prospect (2016-2026)
        1.5.6 South America Oncolytic Virus Therapy Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Oncolytic Virus Therapy Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Oncolytic Virus Therapy Market Drivers
        1.6.2 Oncolytic Virus Therapy Market Restraints
        1.6.3 Oncolytic Virus Therapy Trends Analysis

2 Company Profiles
    2.1 Amgen
        2.1.1 Amgen Details
        2.1.2 Amgen Major Business
        2.1.3 Amgen Oncolytic Virus Therapy Product and Solutions
        2.1.4 Amgen Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Amgen Recent Developments and Future Plans
    2.2 Oncolytics Biotech
        2.2.1 Oncolytics Biotech Details
        2.2.2 Oncolytics Biotech Major Business
        2.2.3 Oncolytics Biotech Oncolytic Virus Therapy Product and Solutions
        2.2.4 Oncolytics Biotech Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Oncolytics Biotech Recent Developments and Future Plans
    2.3 Viralytics
        2.3.1 Viralytics Details
        2.3.2 Viralytics Major Business
        2.3.3 Viralytics Oncolytic Virus Therapy Product and Solutions
        2.3.4 Viralytics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Viralytics Recent Developments and Future Plans
    2.4 Transgene SA
        2.4.1 Transgene SA Details
        2.4.2 Transgene SA Major Business
        2.4.3 Transgene SA Oncolytic Virus Therapy Product and Solutions
        2.4.4 Transgene SA Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Transgene SA Recent Developments and Future Plans
    2.5 Oncolys BioPharma
        2.5.1 Oncolys BioPharma Details
        2.5.2 Oncolys BioPharma Major Business
        2.5.3 Oncolys BioPharma Oncolytic Virus Therapy Product and Solutions
        2.5.4 Oncolys BioPharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Oncolys BioPharma Recent Developments and Future Plans
    2.6 Targovax
        2.6.1 Targovax Details
        2.6.2 Targovax Major Business
        2.6.3 Targovax Oncolytic Virus Therapy Product and Solutions
        2.6.4 Targovax Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Targovax Recent Developments and Future Plans
    2.7 PsiOxus Therapeutics
        2.7.1 PsiOxus Therapeutics Details
        2.7.2 PsiOxus Therapeutics Major Business
        2.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Product and Solutions
        2.7.4 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 PsiOxus Therapeutics Recent Developments and Future Plans
    2.8 SillaJen Biotherapeutics
        2.8.1 SillaJen Biotherapeutics Details
        2.8.2 SillaJen Biotherapeutics Major Business
        2.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Product and Solutions
        2.8.4 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 SillaJen Biotherapeutics Recent Developments and Future Plans
    2.9 Sorrento Therapeutics
        2.9.1 Sorrento Therapeutics Details
        2.9.2 Sorrento Therapeutics Major Business
        2.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Product and Solutions
        2.9.4 Sorrento Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Sorrento Therapeutics Recent Developments and Future Plans
    2.10 Lokon Pharma
        2.10.1 Lokon Pharma Details
        2.10.2 Lokon Pharma Major Business
        2.10.3 Lokon Pharma Oncolytic Virus Therapy Product and Solutions
        2.10.4 Lokon Pharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Lokon Pharma Recent Developments and Future Plans
    2.11 Genelux Corporation
        2.11.1 Genelux Corporation Details
        2.11.2 Genelux Corporation Major Business
        2.11.3 Genelux Corporation Oncolytic Virus Therapy Product and Solutions
        2.11.4 Genelux Corporation Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Genelux Corporation Recent Developments and Future Plans
    2.12 Vyriad
        2.12.1 Vyriad Details
        2.12.2 Vyriad Major Business
        2.12.3 Vyriad Oncolytic Virus Therapy Product and Solutions
        2.12.4 Vyriad Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 Vyriad Recent Developments and Future Plans
    2.13 TILT Biotherapeutics
        2.13.1 TILT Biotherapeutics Details
        2.13.2 TILT Biotherapeutics Major Business
        2.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Product and Solutions
        2.13.4 TILT Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 TILT Biotherapeutics Recent Developments and Future Plans
    2.14 Cold Genesys
        2.14.1 Cold Genesys Details
        2.14.2 Cold Genesys Major Business
        2.14.3 Cold Genesys Oncolytic Virus Therapy Product and Solutions
        2.14.4 Cold Genesys Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 Cold Genesys Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Oncolytic Virus Therapy Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Oncolytic Virus Therapy Players Market Share
        3.2.2 Top 10 Oncolytic Virus Therapy Players Market Share
        3.2.3 Market Competition Trend
    3.3 Oncolytic Virus Therapy Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Oncolytic Virus Therapy Revenue and Market Share by Type (2016-2021)
    4.2 Global Oncolytic Virus Therapy Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
    5.1 Global Oncolytic Virus Therapy Revenue Market Share by Application (2016-2021)
    5.2 Oncolytic Virus Therapy Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
    6.1 North America Oncolytic Virus Therapy Revenue by Type (2016-2026)
    6.2 North America Oncolytic Virus Therapy Revenue by Application (2016-2026)
    6.3 North America Oncolytic Virus Therapy Market Size by Country
        6.3.1 North America Oncolytic Virus Therapy Revenue by Country (2016-2026)
        6.3.2 United States Oncolytic Virus Therapy Market Size and Forecast (2016-2026)
        6.3.3 Canada Oncolytic Virus Therapy Market Size and Forecast (2016-2026)
        6.3.4 Mexico Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
    7.1 Europe Oncolytic Virus Therapy Revenue by Type (2016-2026)
    7.2 Europe Oncolytic Virus Therapy Revenue by Application (2016-2026)
    7.3 Europe Oncolytic Virus Therapy Market Size by Country
        7.3.1 Europe Oncolytic Virus Therapy Revenue by Country (2016-2026)
        7.3.2 Germany Oncolytic Virus Therapy Market Size and Forecast (2016-2026)
        7.3.3 France Oncolytic Virus Therapy Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Oncolytic Virus Therapy Market Size and Forecast (2016-2026)
        7.3.5 Russia Oncolytic Virus Therapy Market Size and Forecast (2016-2026)
        7.3.6 Italy Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Oncolytic Virus Therapy Revenue by Type (2016-2026)
    8.2 Asia-Pacific Oncolytic Virus Therapy Revenue by Application (2016-2026)
    8.3 Asia-Pacific Oncolytic Virus Therapy Market Size by Region
        8.3.1 Asia-Pacific Oncolytic Virus Therapy Revenue by Region (2016-2026)
        8.3.2 China Oncolytic Virus Therapy Market Size and Forecast (2016-2026)
        8.3.3 Japan Oncolytic Virus Therapy Market Size and Forecast (2016-2026)
        8.3.4 South Korea Oncolytic Virus Therapy Market Size and Forecast (2016-2026)
        8.3.5 India Oncolytic Virus Therapy Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Oncolytic Virus Therapy Market Size and Forecast (2016-2026)
        8.3.7 Australia Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
    9.1 South America Oncolytic Virus Therapy Revenue by Type (2016-2026)
    9.2 South America Oncolytic Virus Therapy Revenue by Application (2016-2026)
    9.3 South America Oncolytic Virus Therapy Market Size by Country
        9.3.1 South America Oncolytic Virus Therapy Revenue by Country (2016-2026)
        9.3.2 Brazil Oncolytic Virus Therapy Market Size and Forecast (2016-2026)
        9.3.3 Argentina Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Oncolytic Virus Therapy Revenue by Type (2016-2026)
    10.2 Middle East & Africa Oncolytic Virus Therapy Revenue by Application (2016-2026)
    10.3 Middle East & Africa Oncolytic Virus Therapy Market Size by Country
        10.3.1 Middle East & Africa Oncolytic Virus Therapy Revenue by Country (2016-2026)
        10.3.2 Turkey Oncolytic Virus Therapy Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Oncolytic Virus Therapy Market Size and Forecast (2016-2026)
        10.3.4 UAE Oncolytic Virus Therapy Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Oncolytic Virus Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global Oncolytic Virus Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market Oncolytic Virus Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global Oncolytic Virus Therapy Revenue (USD Million) by Region (2016-2021)
    Table 5. Global Oncolytic Virus Therapy Revenue Market Share by Region (2021-2026)
    Table 6. Amgen Corporate Information, Head Office, and Major Competitors
    Table 7. Amgen Major Business
    Table 8. Amgen Oncolytic Virus Therapy Product and Solutions
    Table 9. Amgen Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. Oncolytics Biotech Corporate Information, Head Office, and Major Competitors
    Table 11. Oncolytics Biotech Major Business
    Table 12. Oncolytics Biotech Oncolytic Virus Therapy Product and Solutions
    Table 13. Oncolytics Biotech Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. Viralytics Corporate Information, Head Office, and Major Competitors
    Table 15. Viralytics Major Business
    Table 16. Viralytics Oncolytic Virus Therapy Product and Solutions
    Table 17. Viralytics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. Transgene SA Corporate Information, Head Office, and Major Competitors
    Table 19. Transgene SA Major Business
    Table 20. Transgene SA Oncolytic Virus Therapy Product and Solutions
    Table 21. Transgene SA Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. Oncolys BioPharma Corporate Information, Head Office, and Major Competitors
    Table 23. Oncolys BioPharma Major Business
    Table 24. Oncolys BioPharma Oncolytic Virus Therapy Product and Solutions
    Table 25. Oncolys BioPharma Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. Targovax Corporate Information, Head Office, and Major Competitors
    Table 27. Targovax Major Business
    Table 28. Targovax Oncolytic Virus Therapy Product and Solutions
    Table 29. Targovax Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. PsiOxus Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 31. PsiOxus Therapeutics Major Business
    Table 32. PsiOxus Therapeutics Oncolytic Virus Therapy Product and Solutions
    Table 33. PsiOxus Therapeutics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. SillaJen Biotherapeutics Corporate Information, Head Office, and Major Competitors
    Table 35. SillaJen Biotherapeutics Major Business
    Table 36. SillaJen Biotherapeutics Oncolytic Virus Therapy Product and Solutions
    Table 37. SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 38. Sorrento Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 39. Sorrento Therapeutics Major Business
    Table 40. Sorrento Therapeutics Oncolytic Virus Therapy Product and Solutions
    Table 41. Sorrento Therapeutics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 42. Lokon Pharma Corporate Information, Head Office, and Major Competitors
    Table 43. Lokon Pharma Major Business
    Table 44. Lokon Pharma Oncolytic Virus Therapy Product and Solutions
    Table 45. Lokon Pharma Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 46. Genelux Corporation Corporate Information, Head Office, and Major Competitors
    Table 47. Genelux Corporation Major Business
    Table 48. Genelux Corporation Oncolytic Virus Therapy Product and Solutions
    Table 49. Genelux Corporation Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 50. Vyriad Corporate Information, Head Office, and Major Competitors
    Table 51. Vyriad Major Business
    Table 52. Vyriad Oncolytic Virus Therapy Product and Solutions
    Table 53. Vyriad Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 54. TILT Biotherapeutics Corporate Information, Head Office, and Major Competitors
    Table 55. TILT Biotherapeutics Major Business
    Table 56. TILT Biotherapeutics Oncolytic Virus Therapy Product and Solutions
    Table 57. TILT Biotherapeutics Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 58. Cold Genesys Corporate Information, Head Office, and Major Competitors
    Table 59. Cold Genesys Major Business
    Table 60. Cold Genesys Oncolytic Virus Therapy Product and Solutions
    Table 61. Cold Genesys Oncolytic Virus Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 62. Global Oncolytic Virus Therapy Revenue (USD Million) by Players (2019-2021)
    Table 63. Global Oncolytic Virus Therapy Revenue Share by Players (2019-2021)
    Table 64. Breakdown of Oncolytic Virus Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 65. Oncolytic Virus Therapy Players Head Office, Products and Services Provided
    Table 66. Oncolytic Virus Therapy Mergers & Acquisitions in the Past Five Years
    Table 67. Oncolytic Virus Therapy New Entrants and Expansion Plans
    Table 68. Global Oncolytic Virus Therapy Revenue (USD Million) by Type (2016-2021)
    Table 69. Global Oncolytic Virus Therapy Revenue Share by Type (2016-2021)
    Table 70. Global Oncolytic Virus Therapy Revenue Forecast by Type (2021-2026)
    Table 71. Global Oncolytic Virus Therapy Revenue by Application (2016-2021)
    Table 72. Global Oncolytic Virus Therapy Revenue Forecast by Application (2021-2026)
    Table 73. North America Oncolytic Virus Therapy Revenue by Type (2016-2021) & (USD Million)
    Table 74. North America Oncolytic Virus Therapy Revenue by Type (2021-2026) & (USD Million)
    Table 75. North America Oncolytic Virus Therapy Revenue by Application (2016-2021) & (USD Million)
    Table 76. North America Oncolytic Virus Therapy Revenue by Application (2021-2026) & (USD Million)
    Table 77. North America Oncolytic Virus Therapy Revenue by Country (2016-2021) & (USD Million)
    Table 78. North America Oncolytic Virus Therapy Revenue by Country (2021-2026) & (USD Million)
    Table 79. Europe Oncolytic Virus Therapy Revenue by Type (2016-2021) & (USD Million)
    Table 80. Europe Oncolytic Virus Therapy Revenue by Type (2021-2026) & (USD Million)
    Table 81. Europe Oncolytic Virus Therapy Revenue by Application (2016-2021) & (USD Million)
    Table 82. Europe Oncolytic Virus Therapy Revenue by Application (2021-2026) & (USD Million)
    Table 83. Europe Oncolytic Virus Therapy Revenue by Country (2016-2021) & (USD Million)
    Table 84. Europe Oncolytic Virus Therapy Revenue by Country (2021-2026) & (USD Million)
    Table 85. Asia-Pacific Oncolytic Virus Therapy Revenue by Type (2016-2021) & (USD Million)
    Table 86. Asia-Pacific Oncolytic Virus Therapy Revenue by Type (2021-2026) & (USD Million)
    Table 87. Asia-Pacific Oncolytic Virus Therapy Revenue by Application (2016-2021) & (USD Million)
    Table 88. Asia-Pacific Oncolytic Virus Therapy Revenue by Application (2021-2026) & (USD Million)
    Table 89. Asia-Pacific Oncolytic Virus Therapy Revenue by Region (2016-2021) & (USD Million)
    Table 90. Asia-Pacific Oncolytic Virus Therapy Revenue by Region (2021-2026) & (USD Million)
    Table 91. South America Oncolytic Virus Therapy Revenue by Type (2016-2021) & (USD Million)
    Table 92. South America Oncolytic Virus Therapy Revenue by Type (2021-2026) & (USD Million)
    Table 93. South America Oncolytic Virus Therapy Revenue by Application (2016-2021) & (USD Million)
    Table 94. South America Oncolytic Virus Therapy Revenue by Application (2021-2026) & (USD Million)
    Table 95. South America Oncolytic Virus Therapy Revenue by Country (2016-2021) & (USD Million)
    Table 96. South America Oncolytic Virus Therapy Revenue by Country (2021-2026) & (USD Million)
    Table 97. Middle East & Africa Oncolytic Virus Therapy Revenue by Type (2016-2021) & (USD Million)
    Table 98. Middle East & Africa Oncolytic Virus Therapy Revenue by Type (2021-2026) & (USD Million)
    Table 99. Middle East & Africa Oncolytic Virus Therapy Revenue by Application (2016-2021) & (USD Million)
    Table 100. Middle East & Africa Oncolytic Virus Therapy Revenue by Application (2021-2026) & (USD Million)
    Table 101. Middle East & Africa Oncolytic Virus Therapy Revenue by Country (2016-2021) & (USD Million)
    Table 102. Middle East & Africa Oncolytic Virus Therapy Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. Oncolytic Virus Therapy Picture
    Figure 2. Global Oncolytic Virus Therapy Revenue Market Share by Type in 2020
    Figure 3. HSV-based Oncolytic Viruses
    Figure 4. Adenoviruses-based Oncolytic Viruses
    Figure 5. Vaccinia Virus-based Oncolytic Viruses
    Figure 6. Vesicular Stomatitis Virus-based Oncolytic Viruses
    Figure 7. Newcastle Disease Virus-based Oncolytic Viruses
    Figure 8. Oncolytic Virus Therapy Revenue Market Share by Application in 2020
    Figure 9. Melanoma Picture
    Figure 10. Prostate Cancer Picture
    Figure 11. Breast Cancer Picture
    Figure 12. Ovarian Cancer Picture
    Figure 13. Others Picture
    Figure 14. Global Oncolytic Virus Therapy Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 15. Global Oncolytic Virus Therapy Revenue and Forecast (2016-2026) & (USD Million)
    Figure 16. Global Oncolytic Virus Therapy Revenue Market Share by Region (2016-2026)
    Figure 17. Global Oncolytic Virus Therapy Revenue Market Share by Region in 2020
    Figure 18. North America Oncolytic Virus Therapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 19. Europe Oncolytic Virus Therapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 20. Asia-Pacific Oncolytic Virus Therapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 21. South America Oncolytic Virus Therapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 22. Middle East and Africa Oncolytic Virus Therapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 23. Oncolytic Virus Therapy Market Drivers
    Figure 24. Oncolytic Virus Therapy Market Restraints
    Figure 25. Oncolytic Virus Therapy Market Trends
    Figure 26. Amgen Recent Developments and Future Plans
    Figure 27. Oncolytics Biotech Recent Developments and Future Plans
    Figure 28. Viralytics Recent Developments and Future Plans
    Figure 29. Transgene SA Recent Developments and Future Plans
    Figure 30. Oncolys BioPharma Recent Developments and Future Plans
    Figure 31. Targovax Recent Developments and Future Plans
    Figure 32. PsiOxus Therapeutics Recent Developments and Future Plans
    Figure 33. SillaJen Biotherapeutics Recent Developments and Future Plans
    Figure 34. Sorrento Therapeutics Recent Developments and Future Plans
    Figure 35. Lokon Pharma Recent Developments and Future Plans
    Figure 36. Genelux Corporation Recent Developments and Future Plans
    Figure 37. Vyriad Recent Developments and Future Plans
    Figure 38. TILT Biotherapeutics Recent Developments and Future Plans
    Figure 39. Cold Genesys Recent Developments and Future Plans
    Figure 40. Global Oncolytic Virus Therapy Revenue Share by Players in 2020
    Figure 41. Oncolytic Virus Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 42. Global Top 3 Players Oncolytic Virus Therapy Revenue Market Share in 2020
    Figure 43. Global Top 10 Players Oncolytic Virus Therapy Revenue Market Share in 2020
    Figure 44. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 45. Global Oncolytic Virus Therapy Revenue Share by Type in 2020
    Figure 46. Global Oncolytic Virus Therapy Market Share Forecast by Type (2021-2026)
    Figure 47. Global Oncolytic Virus Therapy Revenue Share by Application in 2020
    Figure 48. Global Oncolytic Virus Therapy Market Share Forecast by Application (2021-2026)
    Figure 49. North America Oncolytic Virus Therapy Sales Market Share by Type (2016-2026)
    Figure 50. North America Oncolytic Virus Therapy Sales Market Share by Application (2016-2026)
    Figure 51. North America Oncolytic Virus Therapy Revenue Market Share by Country (2016-2026)
    Figure 52. United States Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 53. Canada Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 54. Mexico Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 55. Europe Oncolytic Virus Therapy Sales Market Share by Type (2016-2026)
    Figure 56. Europe Oncolytic Virus Therapy Sales Market Share by Application (2016-2026)
    Figure 57. Europe Oncolytic Virus Therapy Revenue Market Share by Country (2016-2026)
    Figure 58. Germany Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. France Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. United Kingdom Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. Russia Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. Italy Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. Asia-Pacific Oncolytic Virus Therapy Sales Market Share by Type (2016-2026)
    Figure 64. Asia-Pacific Oncolytic Virus Therapy Sales Market Share by Application (2016-2026)
    Figure 65. Asia-Pacific Oncolytic Virus Therapy Revenue Market Share by Region (2016-2026)
    Figure 66. China Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. Japan Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. South Korea Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 69. India Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 70. Southeast Asia Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 71. Australia Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 72. South America Oncolytic Virus Therapy Sales Market Share by Type (2016-2026)
    Figure 73. South America Oncolytic Virus Therapy Sales Market Share by Application (2016-2026)
    Figure 74. South America Oncolytic Virus Therapy Revenue Market Share by Country (2016-2026)
    Figure 75. Brazil Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 76. Argentina Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 77. Middle East and Africa Oncolytic Virus Therapy Sales Market Share by Type (2016-2026)
    Figure 78. Middle East and Africa Oncolytic Virus Therapy Sales Market Share by Application (2016-2026)
    Figure 79. Middle East and Africa Oncolytic Virus Therapy Revenue Market Share by Country (2016-2026)
    Figure 80. Turkey Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 81. Saudi Arabia Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 82. UAE Oncolytic Virus Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys

Related Reports

Global Oncolytic Virus Therapy Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Oncolytic Virus Therapy Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 04 Jan 2022

date Medical Care

The Oncolytic Virus Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Oncolytic Virus Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Oncolytic Virus Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Medical Care

Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

Global Oncolytic Virus Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Oncolytic Virus Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Oncolytic Virus Therapy market size was valued at USD 6 million in 2023 and is forecast to a readjusted size of USD 28 million by 2030 with a CAGR of 23.8% during review period.

Global Oncolytic Virus Therapy Supply, Demand and Key Producers, 2024-2030

Global Oncolytic Virus Therapy Supply, Demand and Key Producers, 2024-2030

date 10 Feb 2024

date Medical Care

The global Oncolytic Virus Therapy market size is expected to reach $ 28 million by 2030, rising at a market growth of 23.8% CAGR during the forecast period (2024-2030).

Product Tags

oncolytic virus therapy

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>